BACKGROUND: It is known that cigarette smoking is associated with an approximately 50% increase in leukemia risk. In order to detect a possible influence of cigarette smoking on initial characteristics at the time of presentation and on the course of the disease, we conducted a retrospective study in 643 patients with newly diagnosed acute myeloid leukemia. PATIENTS AND METHODS: The study comprised 339 males and 304 females (median age 59 years, range 18-84 years). Two hundred and ninety-six patients (46%), smoking at least one cigarette per day for 6 months, were considered as smokers, while 347 patients (54%) were non-smokers. RESULTS: Cigarette smoking was significantly related to male gender (P <0.0001), professional occupancy (P = 0.002), presence of organomegaly (P = 0.01), and lower peripheral blood and bone marrow leukemic cell involvement (P = 0.007 and P = 0.0001, respectively). Leukemia of French-American-British (FAB) M1 subtype was more frequent in non-smokers (P = 0.005). Although not statistically significant, smokers tended to have lower leukocyte counts than non-smokers. No difference was noted in terms of complete remission rates between smokers and non-smokers (67% compared to 64%). However, a higher rate of severe pulmonary infection was observed in smokers during induction chemotherapy (P = 0.02). Cigarette smoking (>or=20 pack-years or smoking duration >or=30 years) was significantly associated with shorter disease-free survival (P = 0.03) and overall survival (OS; P = 0.02 and P = 0.004, respectively). Other characteristics associated with poor prognosis included mainly older age, unfavorable karyotype, secondary acute myeloid leukemia (AML) and elevated World Health Organization (WHO) performance status. Cigarette smoking was associated with shorter OS in younger adults, but did not significantly influence survival in patients >60 years old. Cigarette smoking worsened the poor OS in patients with unfavorable karyotype, but did not significantly influence the prognosis of other karyotypic risk groups. In a multivariate analysis, only karyotypic grouping and age remained of prognostic value for the occurrence of disease-free and overall survival. CONCLUSIONS: Cigarette smoking has a deleterious effect on survival in AML by shortening complete remission duration and subsequent survival. It was associated with severe infections during aplasia. Leukemogenic compounds favoring complex karyotypic abnormalities could also be involved.
BACKGROUND: It is known that cigarette smoking is associated with an approximately 50% increase in leukemia risk. In order to detect a possible influence of cigarette smoking on initial characteristics at the time of presentation and on the course of the disease, we conducted a retrospective study in 643 patients with newly diagnosed acute myeloid leukemia. PATIENTS AND METHODS: The study comprised 339 males and 304 females (median age 59 years, range 18-84 years). Two hundred and ninety-six patients (46%), smoking at least one cigarette per day for 6 months, were considered as smokers, while 347 patients (54%) were non-smokers. RESULTS: Cigarette smoking was significantly related to male gender (P <0.0001), professional occupancy (P = 0.002), presence of organomegaly (P = 0.01), and lower peripheral blood and bone marrow leukemic cell involvement (P = 0.007 and P = 0.0001, respectively). Leukemia of French-American-British (FAB) M1 subtype was more frequent in non-smokers (P = 0.005). Although not statistically significant, smokers tended to have lower leukocyte counts than non-smokers. No difference was noted in terms of complete remission rates between smokers and non-smokers (67% compared to 64%). However, a higher rate of severe pulmonary infection was observed in smokers during induction chemotherapy (P = 0.02). Cigarette smoking (>or=20 pack-years or smoking duration >or=30 years) was significantly associated with shorter disease-free survival (P = 0.03) and overall survival (OS; P = 0.02 and P = 0.004, respectively). Other characteristics associated with poor prognosis included mainly older age, unfavorable karyotype, secondary acute myeloid leukemia (AML) and elevated World Health Organization (WHO) performance status. Cigarette smoking was associated with shorter OS in younger adults, but did not significantly influence survival in patients >60 years old. Cigarette smoking worsened the poor OS in patients with unfavorable karyotype, but did not significantly influence the prognosis of other karyotypic risk groups. In a multivariate analysis, only karyotypic grouping and age remained of prognostic value for the occurrence of disease-free and overall survival. CONCLUSIONS: Cigarette smoking has a deleterious effect on survival in AML by shortening complete remission duration and subsequent survival. It was associated with severe infections during aplasia. Leukemogenic compounds favoring complex karyotypic abnormalities could also be involved.
Authors: Xiaomei Ma; Rong Wang; Naomi Galili; Susan T Mayne; Sa A Wang; Herbert Yu; Azra Raza Journal: Cancer Causes Control Date: 2011-02-02 Impact factor: 2.506
Authors: Mohamed L Sorror; Sergio Giralt; Brenda M Sandmaier; Marcos De Lima; Munir Shahjahan; David G Maloney; H Joachim Deeg; Frederick R Appelbaum; Barry Storer; Rainer Storb Journal: Blood Date: 2007-09-14 Impact factor: 22.113
Authors: H Naik; X Qiu; M C Brown; L Eng; D Pringle; M Mahler; H Hon; K Tiessen; H Thai; V Ho; C Gonos; R Charow; V Pat; M Irwin; L Herzog; A Ho; W Xu; J M Jones; D Howell; G Liu Journal: Curr Oncol Date: 2016-12-21 Impact factor: 3.677
Authors: Uwe A Wittel; Navneet Momi; Gabriel Seifert; Thorsten Wiech; Ulrich T Hopt; Surinder K Batra Journal: Int J Oncol Date: 2012-03-23 Impact factor: 5.650
Authors: Catherine Metayer; Eleni Petridou; Juan Manuel Mejía Aranguré; Eve Roman; Joachim Schüz; Corrado Magnani; Ana Maria Mora; Beth A Mueller; Maria S Pombo de Oliveira; John D Dockerty; Kathryn McCauley; Tracy Lightfoot; Emmanouel Hatzipantelis; Jérémie Rudant; Janet Flores-Lujano; Peter Kaatsch; Lucia Miligi; Catharina Wesseling; David R Doody; Maria Moschovi; Laurent Orsi; Stefano Mattioli; Steve Selvin; Alice Y Kang; Jacqueline Clavel Journal: Am J Epidemiol Date: 2016-08-03 Impact factor: 4.897
Authors: Devon Alton; Lawson Eng; Lin Lu; Yuyao Song; Jie Su; Delaram Farzanfar; Rahul Mohan; Olivia Krys; Katie Mattina; Christopher Harper; Sophia Liu; Tom Yoannidis; Robin Milne; M Catherine Brown; Ashlee Vennettilli; Andrew J Hope; Doris Howell; Jennifer M Jones; Peter Selby; Wei Xu; David P Goldstein; Geoffrey Liu; Meredith E Giuliani Journal: J Oncol Pract Date: 2018-04-20 Impact factor: 3.840
Authors: Carla J Berg; Akilah N Thomas; Ann C Mertens; Gillian L Schauer; Erika A Pinsker; Jasjit S Ahluwalia; Fadlo R Khuri Journal: Psychooncology Date: 2012-04-09 Impact factor: 3.894